Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao HeInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, ChinaLiuhui FuInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, ChinaYiping LiInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, ChinaWenyan WangInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, ChinaMingli GongInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, ChinaJing ZhangInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, ChinaXin DongInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, ChinaJiaoyan HuangInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, ChinaQuanbo WangSchool of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, ChinaCharles R. MackayMonash UniversityYang‐Xin FuDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USAYun ChenDepartment of Immunology, Key Laboratory of Immune Microenvironment and Disease, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China; Research center for clinical oncology, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210018, ChinaXiaohuan GuoInstitute for Immunology, School of Medicine, Tsinghua University, Beijing 100084, China; Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 100084, China. Electronic address: [email protected]
2021en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0